Story · Medicine & Biotech

3 takeaways from TCT 2026

1 outlet · first reported by MedTech Dive on

Edwards’ TAVR device in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation and Abbott’s left atrial appendage closure devices also produced positive study results. (MedTech Dive)

Coverage, in order

  1. MedTech Dive indie
    3 takeaways from TCT 2026

    Edwards’ TAVR device in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation and Abbott’s left atrial appendage closure devices also produced positive study results.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.